The effects of midodrine hydrochloride (Brand name: Metligine tablet 2 mg, Manufacturer: Taisho Pharmaceutical Co., Ltd.), alpha-1 adrenalin receptor agonist against urinary incontinence was examined on 5 female patients with stress urinary incontinence and 5 male urinary incontinent patients of various causes. Metligine was administered in the dose of 4 mg daily for 2 to 4 weeks. Eighty per cent of the stress incontinent patients showed improvement and five incontinent male also showed improvement of symptoms. No side effects were recognized.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
midodrine hydrochloride
8
urinary incontinence
8
incontinent patients
8
[clinical midodrine
4
patients
4
hydrochloride patients
4
urinary
4
patients urinary
4
urinary incontinence]
4
incontinence] effects
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!